| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | AMGEN INC | 96,500 | 14,109,000 | 0.94% | ||
| 102 | PROTHENA CORP PLC | 309,500 | 15,224,000 | 1.02% | ||
| 103 | Wright Medical Group NV | 667,000 | 15,328,000 | 1.03% | ||
| 104 | AMARIN CORP PLC | 4,991,500 | 15,374,000 | 1.03% | ||
| 105 | NEUROCRINE BIOSCIE COM USD0.001 | 410,000 | 15,867,000 | 1.06% | ||
| 106 | PRA HEALTH SCIENCES INC | 300,000 | 16,536,000 | 1.11% | ||
| 107 | INCYTE CORP | 169,000 | 16,946,000 | 1.13% | ||
| 108 | PENUMBRA INC COM | 295,500 | 18,853,000 | 1.26% | ||
| 109 | Theravance Biopharma Inc | 600,000 | 19,128,000 | 1.28% | ||
| 110 | GILEAD SCIENCES INC | 276,500 | 19,800,000 | 1.32% | ||
| 111 | PACIRA PHARMACEUTICALS INC | 713,000 | 23,030,000 | 1.54% | ||
| 112 | SHIRE PLC | 137,200 | 23,376,000 | 1.56% | ||
| 113 | MEDICINES CO | 699,500 | 23,741,000 | 1.59% | ||
| 114 | LILLY ELI & CO | 325,000 | 23,904,000 | 1.60% | ||
| 115 | ADVANCED ACCELERATOR APPLIC | 930,000 | 24,887,000 | 1.67% | ||
| 116 | COLLEGIUM PHARMACEUTICAL INC COM | 1,600,000 | 24,912,000 | 1.67% | ||
| 117 | BRISTOL MYERS SQUIBB CO | 450,000 | 26,298,000 | 1.76% | ||
| 118 | UNITEDHEALTH GROUP INC | 165,000 | 26,407,000 | 1.77% | ||
| 119 | CELGENE CORP | 242,500 | 28,069,000 | 1.88% | ||
| 120 | ARDELYX INC COM | 2,000,000 | 28,400,000 | 1.90% | ||
| 121 | ACLARIS THERAPEUTICS INC COM | 1,100,000 | 29,854,000 | 2.00% | ||
| 122 | INTUITIVE SURGICAL INC | 48,000 | 30,440,000 | 2.04% | ||
| 123 | SPARK THERAPEUTICS INCORPORATED | 625,000 | 31,188,000 | 2.09% | ||
| 124 | WELLCARE HEALTH PLANS INC | 234,500 | 32,145,000 | 2.15% | ||
| 125 | CIGNA CORPORATION | 252,000 | 33,614,000 | 2.25% | ||
| 126 | RADIUS HEALTH INCORPORATED COM NEW | 910,250 | 34,617,000 | 2.32% | ||
| 127 | ALLERGAN PLC | 166,000 | 34,862,000 | 2.33% | ||
| 128 | ACADIA COMPANY COM | 1,157,500 | 38,313,000 | 2.56% | ||
| 129 | GW PHARMACEUTICALS PLC | 356,000 | 39,783,000 | 2.66% | ||
| 130 | MERCK & CO INC | 750,000 | 44,153,000 | 2.95% | ||
| 131 | AETNA INC NEW | 441,000 | 54,688,000 | 3.66% | ||
| 132 | ALEXION PHARMACEUTIC | 465,000 | 56,893,000 | 3.81% | ||
| 133 | TESARO INCORPORATED | 613,500 | 82,503,000 | 5.52% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-17-000700, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
